Cargando…

Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain

Rhodopsin is a prototypical G protein-coupled receptor (GPCR) critical for vertebrate vision. Research on GPCR signaling states has been facilitated using llama-derived nanobodies (Nbs), some of which bind to the intracellular surface to allosterically modulate the receptor. Extracellularly binding...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Arum, Salom, David, Hong, John D., Tworak, Aleksander, Watanabe, Kohei, Pardon, Els, Steyaert, Jan, Kandori, Hideki, Katayama, Kota, Kiser, Philip D., Palczewski, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457330/
https://www.ncbi.nlm.nih.gov/pubmed/37626045
http://dx.doi.org/10.1038/s41467-023-40911-9
_version_ 1785096898571403264
author Wu, Arum
Salom, David
Hong, John D.
Tworak, Aleksander
Watanabe, Kohei
Pardon, Els
Steyaert, Jan
Kandori, Hideki
Katayama, Kota
Kiser, Philip D.
Palczewski, Krzysztof
author_facet Wu, Arum
Salom, David
Hong, John D.
Tworak, Aleksander
Watanabe, Kohei
Pardon, Els
Steyaert, Jan
Kandori, Hideki
Katayama, Kota
Kiser, Philip D.
Palczewski, Krzysztof
author_sort Wu, Arum
collection PubMed
description Rhodopsin is a prototypical G protein-coupled receptor (GPCR) critical for vertebrate vision. Research on GPCR signaling states has been facilitated using llama-derived nanobodies (Nbs), some of which bind to the intracellular surface to allosterically modulate the receptor. Extracellularly binding allosteric nanobodies have also been investigated, but the structural basis for their activity has not been resolved to date. Here, we report a library of Nbs that bind to the extracellular surface of rhodopsin and allosterically modulate the thermodynamics of its activation process. Crystal structures of Nb2 in complex with native rhodopsin reveal a mechanism of allosteric modulation involving extracellular loop 2 and native glycans. Nb2 binding suppresses Schiff base deprotonation and hydrolysis and prevents intracellular outward movement of helices five and six – a universal activation event for GPCRs. Nb2 also mitigates protein misfolding in a disease-associated mutant rhodopsin. Our data show the power of nanobodies to modulate the photoactivation of rhodopsin and potentially serve as therapeutic agents for disease-associated rhodopsin misfolding.
format Online
Article
Text
id pubmed-10457330
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104573302023-08-27 Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain Wu, Arum Salom, David Hong, John D. Tworak, Aleksander Watanabe, Kohei Pardon, Els Steyaert, Jan Kandori, Hideki Katayama, Kota Kiser, Philip D. Palczewski, Krzysztof Nat Commun Article Rhodopsin is a prototypical G protein-coupled receptor (GPCR) critical for vertebrate vision. Research on GPCR signaling states has been facilitated using llama-derived nanobodies (Nbs), some of which bind to the intracellular surface to allosterically modulate the receptor. Extracellularly binding allosteric nanobodies have also been investigated, but the structural basis for their activity has not been resolved to date. Here, we report a library of Nbs that bind to the extracellular surface of rhodopsin and allosterically modulate the thermodynamics of its activation process. Crystal structures of Nb2 in complex with native rhodopsin reveal a mechanism of allosteric modulation involving extracellular loop 2 and native glycans. Nb2 binding suppresses Schiff base deprotonation and hydrolysis and prevents intracellular outward movement of helices five and six – a universal activation event for GPCRs. Nb2 also mitigates protein misfolding in a disease-associated mutant rhodopsin. Our data show the power of nanobodies to modulate the photoactivation of rhodopsin and potentially serve as therapeutic agents for disease-associated rhodopsin misfolding. Nature Publishing Group UK 2023-08-25 /pmc/articles/PMC10457330/ /pubmed/37626045 http://dx.doi.org/10.1038/s41467-023-40911-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Wu, Arum
Salom, David
Hong, John D.
Tworak, Aleksander
Watanabe, Kohei
Pardon, Els
Steyaert, Jan
Kandori, Hideki
Katayama, Kota
Kiser, Philip D.
Palczewski, Krzysztof
Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
title Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
title_full Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
title_fullStr Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
title_full_unstemmed Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
title_short Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
title_sort structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457330/
https://www.ncbi.nlm.nih.gov/pubmed/37626045
http://dx.doi.org/10.1038/s41467-023-40911-9
work_keys_str_mv AT wuarum structuralbasisfortheallostericmodulationofrhodopsinbynanobodybindingtoitsextracellulardomain
AT salomdavid structuralbasisfortheallostericmodulationofrhodopsinbynanobodybindingtoitsextracellulardomain
AT hongjohnd structuralbasisfortheallostericmodulationofrhodopsinbynanobodybindingtoitsextracellulardomain
AT tworakaleksander structuralbasisfortheallostericmodulationofrhodopsinbynanobodybindingtoitsextracellulardomain
AT watanabekohei structuralbasisfortheallostericmodulationofrhodopsinbynanobodybindingtoitsextracellulardomain
AT pardonels structuralbasisfortheallostericmodulationofrhodopsinbynanobodybindingtoitsextracellulardomain
AT steyaertjan structuralbasisfortheallostericmodulationofrhodopsinbynanobodybindingtoitsextracellulardomain
AT kandorihideki structuralbasisfortheallostericmodulationofrhodopsinbynanobodybindingtoitsextracellulardomain
AT katayamakota structuralbasisfortheallostericmodulationofrhodopsinbynanobodybindingtoitsextracellulardomain
AT kiserphilipd structuralbasisfortheallostericmodulationofrhodopsinbynanobodybindingtoitsextracellulardomain
AT palczewskikrzysztof structuralbasisfortheallostericmodulationofrhodopsinbynanobodybindingtoitsextracellulardomain